Jean De Vry - Concepedia

Author

Jean De Vry

Bayer (Germany)

Also Known As

J De Vry, J de Vry, J. De Vry, J. Vry, J. de Vry, Jean Be Vry, Jean De Vry, Jean de Vry, de Vry, J.

166

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Grünenthal Group (Germany)Stadtwerke Köln (Germany)Utrecht University

About

Jean De Vry is an author at Bayer (Germany) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	70	3.5K
2	Social Sciences	26	40	1.9K
3	Health Sciences	17	20	1K
4	Natural Sciences	1	1	40
5	Allergy	1	1	27

Jean De Vry

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
(–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties Thomas Tzschentke, Thomas Christoph, Babette Kögel, Journal of Pharmacology and Experimental Therapeutics	2007	389
Pharmacological characterization of the chronic constriction injury model of neuropathic pain Jean De Vry, Ellen Kuhl, Petra Franken‐Kunkel, European Journal of Pharmacology Pain SyndromePharmacological CharacterizationHealth SciencesAcute PainNeurophysiology	2004	178
Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs Jean De Vry, Ulrich Benz, Rudy Schreiber, European Journal of Pharmacology Putative Anti-anxiety DrugsPsychiatryShock-induced Ultrasonic VocalizationBehavioral PharmacologyNeuropharmacology	1993	177
Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist Klaus Linz, Thomas Christoph, Thomas Tzschentke, Journal of Pharmacology and Experimental Therapeutics	2014	162
An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia Heinz Häfner, Stephan Behrens, Jean De Vry, Psychiatry Research Behavioral SciencesPsychiatryBehavioral NeuroscienceAnimal ModelSex Differences	1991	161
Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain Thomas Christoph, Babette Kögel, Klaus Schiene, European Journal of Pharmacology Health SciencesAcute PainAddictionPain MedicineMedicine	2004	150
Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat Rudy Schreiber, Jean De Vry European Journal of Pharmacology Behavioral NeuroscienceNeurophysiologyMedicinePhysiologyNeuropharmacology	1993	139
The Novel α7 Nicotinic Acetylcholine Receptor Agonist N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents Frank Boess, Jean De Vry, Christina Erb, Journal of Pharmacology and Experimental Therapeutics	2007	139
Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. Jean De Vry, Inge Donselaar, Jan M. van Ree Journal of Pharmacology and Experimental Therapeutics	1989	134
Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain Wolfgang Schröder, Jean De Vry, Thomas Tzschentke, European Journal of Pain	2010	130

Page 1